Affordable Access

deepdyve-link
Publisher Website

What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli.

Authors
  • Banerjee, Ritu1
  • Starke, Jeffrey R2
  • 1 Division of Pediatric Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. , (United States)
  • 2 Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States. , (United States)
Type
Published Article
Journal
Journal of clinical tuberculosis and other mycobacterial diseases
Publication Date
May 01, 2016
Volume
3
Pages
28–34
Identifiers
DOI: 10.1016/j.jctube.2016.03.004
PMID: 31723682
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

There are striking similarities between the dual pandemics of multidrug-resistant tuberculosis (MDR TB) and multidrug-resistant Gram negative bacilli (MDR GNB) despite fundamental differences in the pathogenesis and epidemiology of these pathogens. In this perspective, we highlight several strategies that have been used by the global TB community to address the MDR TB problem, including approaches to: encourage appropriate use of anti-TB medications, enhance appropriate utilization of molecular diagnostic testing, facilitate development of new antimicrobial agents, and strengthen surveillance systems and infection control practices. Understanding the successes and challenges of these strategies for MDR TB control will be instructive for efforts to curb emergence and spread of MDR GNB. © 2016 The Authors.

Report this publication

Statistics

Seen <100 times